HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Ivacaftor
Description
Ivacaftor (also known as Kalydeco or VX-770) is a drug for the treatment of cystic fibrosis, developed by Vertex Pharmaceuticals and the Cystic Fibrosis Foundation. FDA approved on January 31, 2012.
No brand information found.
